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Diaminas N-monoalquiladas foram sintetizadas e tratadas com D-ribonolactona ou 
D-gliconolactona. As aldonamidas resultantes foram avaliadas para atividade antimicrobiana contra 
S. aureus, E. coli, M. tuberculosis and C. albicans. Duas hidrazidas foram também preparadas a 
partir da ribonoidrazida e suas atividades biológicas comparadas com aquelas de análogos amida. 
Todos os derivados da ribonolactona mostraram ter atividade antitubercular moderada, alguns 
foram ativos também contra S. aureus. 
N-monoalkylated diamines were synthesised and treated with D-ribonolactone or 
D-gluconolactone. The resulting aldonamides were evaluated for their antimicrobial activity 
against S. aureus, E. coli, M. tuberculosis and C. albicans. Two hydrazides were also prepared 
from ribonohydrazide and their biological activity was compared to their amide analogues. All 
the ribono-derivatives displayed moderated antitubercular activity, and some of them were also 
active against S. aureus.
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Introduction
Surfactants are amphiphilic molecules which are 
widely used in many industries. Although conventional 
nonionic surfactants can be produced in large scale from 
petrochemical raw materials, the increasing need for 
biodegradable and less toxic products has led to numerous 
studies of new sugar-based surfactants, which can be 
prepared from natural raw materials.1-11 These compounds 
possess a carbohydrate hydrophilic head (mono- or 
oligosaccharide), and a hydrophobic tail, usually derived 
from a fatty acid. The two moieties can be directly linked 
via a functional group (ester, ether, hydrazine, amine, etc) 
or separated by a spacer (gemini surfactants). Carbohydrate 
surfactants are of great interest because they are not 
noxious for the environment.12,13 Due to their functional 
properties they can be used in several areas, such as food 
industry (emulsion stabilization, foaming),14,15 biology 
(extraction membrane proteins),16 glycobiology,17,18 
immunology,19 detergents, and cosmetology (non-alergic 
compounds). 
Carbohydrate-derivated amphiphilic compounds have 
also been studied for their antimicrobial action.20-24 These 
compounds can display two mechanisms of action. They can 
act as nonionic surfactants: the hydrophilic moiety of surface 
active compounds binds to the hydrophilic portion of the 
membrane via hydrogen bonds. The hydrophobic moiety is 
then able to penetrate the lipid bilayer structure, provocating 
a disorder in the permeability and fluidity of the membrane.25 
They can also act as inhibitors of enzymes involved in the 
biosynthesis of the bacterial cell wall. Galactofuranosyl 
126 and galactopyranosyl derivatives 227 and 328 (Figure 1) 
bearing long alkyl chains displayed antitubercular activity. 
In the last years the intensive use of antibiotic has lead 
to an increase of the emergence of resistant bacteria.29,30 
There is a growing need for new class of antibacterial 
compounds having different mechanism of action compared 
to existing drugs. The antibiotic action of several of these 
drugs involves binding to specific receptors or enzyme 
inhibition, against which bacteria developed strategies, 
like mutation or gene acquisition, leading to resistance.31 
The mechanism by which nonionic surfactants cause cell 
death involves an unspecific interaction with the bacterial 
membrane, difficulting the generation of resistance.
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We report in this work the synthesis and biological 
evaluation of N-alkyl-amino aldonamides from D-glucono-
1,5-lactone and D-ribono-1,4-lactone, as well as two 
hydrazones prepared from D-ribono-1,5-lactone. The 
influence of the hydrophilic portion of the molecule and the 
length of the spacer and of the alkyl chain on antimicrobial 
activity will be discussed.
Results and Discussion
Synthesis of N-alkyl amines were performed according to 
literature procedure,32,33 by treatment of alkyl chlorides 4a-d 
with an excess of 1,2-ethanediamine or 1,3-propanediamine 
in ethanol under reflux, leading to diamine 5a-d and 6a-d 
in 62-70% and 63-74% yield, respectively (Scheme 1). 
Preparation of aldonamides 9a-d, 10a-d, 11a-d,34 
and 12a-c35 was achieved by the nucleophilic addition of 
alkylamines 5a-d and 6a-d to D-glucono-1,5-lactone 7 or 
D-ribono-1,4-lactone 8 (1 equiv/mol) in ethanol for 20 h. 
After purification by crystallization or chromatographic 
column, all compounds were obtained in good to moderate 
yields (Table 1) and were characterized by IR and NMR 
spectroscopy. Spectroscopic data were in full agreement with 
those expected. 1H NMR spectra of compounds 9a-d and 
10a-d showed signals referring to the hydrophobic portion 
of the molecule between 0.8 and 3.0 ppm. Characteristic 
resonances corresponding to the carbohydrate moiety were 
observed between 4.0 and 5.3 ppm, while the diamine 
portion displayed signals in the 3-4 ppm region of the 
spectra. 13C NMR spectra showed signals at ca. 174 (CO 
amide), 76-61 ppm (carbohydrate moiety), 14-50 ppm (alkyl 
chain and methylene carbons of the diamine). Hydrazones 
14 and 15 were obtained by treatment of ribonohydrazide 
1336 with octanaldehyde and decanaldehyde in 93 and 
80% yield respectively (Scheme 2). 1H NMR spectra of 
both compounds showed signals corresponding to the 
alkyl chain (0.8-2.2 ppm) and to the carbohydrate protons 
(4.4-5.3 ppm). The fact that only one signal was observed 
at 7.7 ppm (CH=N) suggested that only the E isomer of the 
hydrazone was formed. 13C NMR spectra showed signals at 
ca. 170 ppm (CO), 152 (CH=N), 74-67 ppm (carbohydrate 
mioety), 33-16 ppm (alkyl chain).
Figure 1.
Scheme 1.
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Biological activity
The in vitro antibacterial activity of compounds 9a-d, 
10a-d, 14, and 15 was evaluated by minimal inhibition 
concentration (MIC) method against Staphylococcus 
aureus ATCC 25923 and Escherichia coli ATCC 25723. 
Antifungal activity was tested against Candida albicans 
ATCC 10231. Compounds 9a-d, 10a-d, 14, 15, 11b-d, and 
12a-c were also tested against Mycobacterium tuberculosis 
virulent strain H37Rv, using the Microplate Alamar Blue 
Assay (MABA method).
The minimum inhibitory concentration (MIC), 
concentration that inhibits the colony forming ability, was 
determined by incorporating decreasing concentrations 
of the tested compound to a culture of the bacteria and 
incubated at 37 ºC for 24 h (M. tuberculosis, E. coli) or 48 h 
(C. albicans). Rifampicin, penicillin-G (400000 UI mg-1), 
nystatin (5914 UI mg-1), and chloramphenicol were used 
as controls. The results are reported in Table 2.
Compounds 9b, 9c, 10a, and 10d, derived from 
D-ribono-1,4-lactone were active against the Gram-positive 
bacteria S. aureus. The most potent compounds were 9c 
and 10d (MIC = 25 µg mL-1). Compounds 9c, 9d and 
10d were also the most active against M. tuberculosis 
(MIC = 25 µg mL-1). Compounds derived from D-glucono-
1,5-lactone have previously been tested against E. coli, S. 
aureus and C. albicans35 and were not tested against these 
organisms in this study. The referenced work showed that 
they were active against S. aureus (MIC = 10-50 ppm), 
compound 12c being the most active one. Due to their low 
solubility only a few derivatives could be tested against M. 
tuberculosis. The most active was 12b (MIC = 50 µg mL-1). 
Hydrazides 14 and 15 displayed low antitubercular activity 
(MIC = 100 µg mL-1) and were inactive against S. aureus 
in the tested concentrations. Compound 10a was the only 
compound with antifungal activity.
These results showed that Gram-positive bacteria S. 
aureus and M. tuberculosis were more sensitive to these 
amphiphilic compounds than Gram-negative E. coli. The 
sensitivity increased with the elongation of hydrocarbon 
chain, and the best results were obtained for compounds 
having an alkyl chain with more than 10 carbons. Gram-
positive bacteria are characterized by having as part of their 
cell wall structure peptidoglycan as well as polysaccharides. 
The hydrogen bonding between the cell wall and the 
hydrophilic moiety is therefore stronger than in Gram-
Scheme 2.
Table 1. Unoptimized yields for ribonamides and gluconamides
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negative bacteria. Having its polar head anchored in the 
membrane, the hydrophobic tail can interact with the lipid 
membrane, causing distortions leading to cell death. This 
mechanism would explain the similar antitubercular activity 
of ribonamide derivatives 9b and 10b and their analogues 
11b and 12b (100 µg mL-1 and 50 µg mL-1, respectively). 
In the same way, the length of the spacer does not interfere 
with the antibacterial activity, and similar results were 
obtained using 1,2-ethanediamine, 1,3-propanediamine or 
an hydrazide linker. 
Conclusion
A series of amphiphilic carbohydrate derivatives were 
synthesized and evaluated as antimicrobial and antifungal 
agents. Almost all of them displayed a moderated activity 
against M. tuberculosis, and some of them were also active 
against S. aureus. Nonionic amphiphilic compounds having 
low antibacterial activity and emulsification potential 
(8 < HLB < 18)36 are suitable compounds for cosmetic 
formulations, as they are less aggressive to skin and cause 
least disturbance in skin flora.37
Experimental
General methods
TLC were performed on glass plates coated with 
silica gel 60G (Merck). Detection was accomplished with 
iodine vapor, by spraying the plates with a solution of 
sulphuric acid in ethanol (20% v/v) or with a ninhydrin 
solution in ethanol (0.5% m/v), followed by heating at 
120 °C. Column chromatography was carried out on silica 
gel (E. Merck 230-400 mesh). Solvents were purchased 
from Vetec Química and were distilled before use. 
Reagents were purchased from Aldrich and used without 
further purification. Melting points were determined on 
a Microquímica MQAPF apparatus and are uncorrected. 
IR spectra were recorded using a BOMEM-FTIR MB102 
spectrometer. Optical rotations were measured with a 
Perkin Elmer 341 polarimeter, using a sodium lamp 
(λ  = 589 nm) at 20 ºC. 1H and 13C NMR spectra were 
recorded on Bruker Advance DRX300 and DRX400 
spectrometer. Elementary analyses were performed by the 
Central Analítica of Instituto de Química of Universidade 
de São Paulo, Brazil. 
Synthesis
General procedure for the obtention of aldonamides
A solution of the lactone (4 mmol) in ethanol (20 mL) 
or in a mixture ethanol/water 1:1 (10 mL) was added to a 
solution of the alkylamine (4 mmol) in ethanol (20 mL). 
The mixture was stirred at room temperature for 24 h and 
concentrated under reduced pressure. The residue was 
chromatographed on silica gel when oily or crystallized 
from water.
N-[2-(N-octyl)-2-aminoethyl]-D-ribonamide 9a: 1.03 g, 
81%; mp 58-60 ºC; [α]
D




N); IR (KBr), 
ν
max
/cm-1: 3390-3340, 2930-2855, 1659, 1540, 1070; 1H 




N): δ 8.67 (s, 1H, CONH,); 5.68 (m, 
4H, OH); 5.12 (m, 1H, H
2
); 4.92 (m, 1H, H3); 4.81-4.47 (m, 
2H, H4, H5’); 4.39 (m, 1H, H5’); 3.80 (m, 2H, CONHCH
2
); 




NH); 2.67 (m, 2H, H6); 1.53 
(m, 2H, H7); 1.18 (m, 10H, CH
2 
aliph.); 0.85 (t, 3H, J 7.1Hz, 
CH
3




N): d 174.7 (C1); 75.8; 74.2; 






















O: C, 53.23; H, 
10.13; N, 8.28. Found: C, 54.21; H, 10.80; N, 7.90%.
N-[2-(N-decyl)-2-aminoethyl]-D-ribonamide 9b: 
1.03 g, 74%; mp 78-81 ºC; [α]
D





Table 2. Antimicrobial and antifungal activity 
ΜΙC/ 
(µg mL-1)
M. tuberculosis S. aureus E. coli C. albicans
9a 100 > 50 > 50 > 50
9b 100 50 > 50 > 50
9c 25 25 > 50 > 50
9d 25 > 50 > 50 > 50
10a 100 50 > 50 50
10b 50 > 50 > 50 > 50
10c 50 > 50 > 50 > 50
10d 25 25 > 50 > 50
11a res n.t. n.t. n.t.
11b 100 n.t. n.t. n.t.
11c n.s. n.t. n.t. n.t.
11d n.s. n.t. n.t. n.t.
12a res n.t. n.t. n.t.
12b 50 n.t. n.t. n.t.
12c n.s. n.t. n.t. n.t.
14 100 > 50 > 50 > 50
15 100 > 50 > 50 > 50
Control 1a 0.5b 5c 20d
(n.s.: not soluble, n.t.: not tested, res.: resistant); arifampicin; bpenicillin-G 
UI mL-1; cchloramphenicol UI mL-1; dnystatin UI mL-1.
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IR (KBr), ν
max
/cm-1: 3412-3355, 2922-2850, 1655, 1537, 




N): d 8.69 (s, 1H, CONH); 
5.50 (m, 4H, OH); 5.16 (m, 1H, H2); 4.84 (m, 1H, H3); 
4.75-4.41 (m, 2H, H4, H5’); 4.39 (m, 1H, H5); 3.62 (m, 
2H, CONHCH
2





(m, 2H, H6); 1.52 (m, 2H, H7); 1.33 (m, 14H, CH
2 
aliph); 
0.86 (t, 3H, J 6.9Hz, CH
3





d 175.3 (C1); 76.5; 75.1; 74.7 (C2, C3, C4); 65.8 (C5); 






















O: C, 53.10; H, 10.49; N, 7.29. Found C 
53.97; H, 11.07; N, 6.99%.
N-[2-(N-dodecyl)-2-aminoethyl]-D-ribonamide 9c: 1.02 
g, 70%; mp 92-95 ºC; [α]
D
 +9.9 (c 1.5; DMSO); IR (KBr), 
ν
max
/cm-1: 3450-3330, 2919-2851, 1650, 1542, 1054; 1H 




N): d 8.59 (s, 1H, CONH); 5.13 (m, 
1H, H2); 4.81 (m, 1H, H3); 4.72-4.38 (m, 2H, H4, H5’); 
4.36 (m, 1H, H5); 3.64 (m, 2H, CONHCH
2
); 2.8 (t, 2H, 




NH); 2.59 (t, 2H, J 6.9 Hz, H6); 
1.48 (m, 2H, H7); 1.24 (m, 14H, CH
2 
aliph.); 0.88 (t, 3H, 
J 6.9Hz, CH
3




N): d 174.5 (C1); 




















: C, 60.61; H, 
10.71; N, 7.44. Found: C, 60.57; H 10.72; N 7.40%.
N-[2-(N-tetradecyl)-2-aminoethyl]-D-ribonamide 9d: 
1.44 g, 90%; mp 94.5-97.2 ºC; [α]
D







/cm-1: 3430-3332, 2920-2856, 1652, 1540, 




N): d 8.59 (s, 1H, NH); 
5.13 (m, 4H, OH); 5.11 (m, 1H, H2); 4.82. (m, 1H, H3); 
4.80-4.39 (m, 2H, H4, H5’); 4.38 (m, 1H, H5); 3.67 (m, 
2H, CONHCH
2





(t, 2H, J 6.8 Hz, H6); 1.51 (m, 2H, H7); 1.27 (m, 22H, CH
2 
aliph.); 0.89 (t, 3H, J 6.6 Hz, CH
3





N); d 174.8 (C1); 75.9; 74.8; 73.8 (C2, C3, C4); 65.1 




















: C, 62.34; H, 10.96; N, 6.92. Found: C, 
62.11; H, 11.07; N, 6.91%.
N-[3-(N-octyl)-3-aminopropyl]-D-ribonamide 10a: Oil, 
1.06 g, 80%; [α]
D




N); IR (CsI) ν
max
/cm-1: 
3450-3398, 2925-2856, 1650, 1541, 1060; 1H NMR (300 
MHz, D
2
O); d 4.25 (d, 1H, J 3.0 Hz, H2); 3.85 (m, 1H, 
H3); 3.71-3.76 (m, 2H, H4, H5’); 3.58 (m, 1H, H5); 3.21 
(m, 2H, CONHCH
2 











NH); 1.46 (m, 2H, CH
2
); 1.23 (m, 10H, 
CH
2 
aliph.); 0.81 (t, 3H, J 6.8 Hz, CH
3
); 13C NMR (75 MHz, 
D
2
O): d 175.8 (C1); 75.5; 74.7; 72.9; (C2, C3, C4); 64.8 




























O: C, 49.47; H, 
10.38; N, 7.21. Found: C, 49.80; H, 9.90; N, 6.88%.
N-[3-(N-decyl)-3-aminopropyl]-D-ribonamide 10b: 
0.87 g, 60%; mp 72-75.5 ºC; [α]
D







/cm-1: 3430-3395, 2930-2860, 1652, 1540, 




N): d 5.11 (m, 4H, OH); 
5.10 (m, 1H, H2); 4.81 (m, 1H, H3); 4.72-4.41 (m, 2H, H4, 
H5’); 4.31 (m, 1H, H5); 3.64 (m, 2H, CONHCH
2
















NH); 1.57 (m, 2H, CH
2
); 1.20 (m, 
14H, CH
2 
aliph.); 0.87 (t, 3H, J 7.1 Hz, CH
3





N): d 175.0 (C1); 76.1-73.5 (C2, C3, C4); 65.8 




























O: C, 54.25; H, 
10.62; N, 7.03. Found: C 54.35; H, 10.57; N, 6.95%.
N-[3-(N-dodecyl)-3-aminopropyl]-D-ribonamide 10c: 
0.95 g, 60%; mp 72-76.5 ºC; [α]
D
 +7.3 (c 1.5; DMSO); 
IR (KBr), ν
max
/cm-1: 3374-3290, 2923-2852, 1650, 1545, 




N): d 5.08 (d, 1H, J 4.4Hz, 
H2); 4.78 (m, 1H, H3); 4.70-4.47 (m, 2H, H4, H5’); 4.36 







2.73 (t, 2H, J 6.3 Hz, CONHCH
2
); 2.55 (t, 2H, J 7.1 Hz, 
NHCH
2






NH); 1.51 (m, 2H, 
CH
2
); 1.23 (m, 18H, CH
2 
aliph.); 0.86 (t, 3H, J 7.1 Hz, 
CH
3




N): d 175.0 (C1); 76.2–





























O: C, 58.79; H, 10.85; N, 6.86. Found: C, 
57.92; H, 10.96; N, 6.79.
N-[3-(N-tetradecyl)-3-aminopropyl]-D-ribonamide 10d: 
1.16 g, 70%; mp 81-85.5 ºC; [α]
D







/cm-1: 3390-3298, 2919-2851, 1650, 1550, 1057; 




N): d 5.07 (m, 4H, OH); 5.06 (m, 
1H, H2); 4.68 (m, 1H, H3); 4.48-4.34 (m, 2H, H4, H5’); 







(t, 2H, J 6.0 Hz, CONHCH
2
); 2.54 (t, 2H, J 7.0 Hz, NHCH
2
); 











aliph.); 0.84 (t, 3H, J 7.0 Hz, CH
3





N): d 174.9 (C1); 76.1-74.5 (C2, C3, C4); 




















31.0 (C17); 23.5-14.8 (CH
2











O: C, 60.52; H, 11.08; N, 6.42. Found: 
C, 60.02; H, 11.08; N, 6.32%.
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N-[2-(N-octyl)-2-aminoethyl]-D-gluconamide 11a: 
0.72 g, 51%; mp 181.7-186.0 °C; IR (KBr) ν
max
/cm-1: 
3533, 3394, 3350, 2954, 2736, 1662, 1533 and 1097; 1H 
NMR (300 MHz, D
2
O): d 4.35 (d, 1H, J 3.0 Hz, H2); 4.10 
(t, 1H, J 3.0 Hz, H3); 3.83-3.76 (m, 1H, H4); 3.75-3.71 
(m, 2H, H6); 3.67-3.64 (m, 1H, H5); 3.63-3.55 (m, 2H, 
CONHCH
2





(t, 2H, J 7.7 Hz, H7); 1.72-1.60 (m, 2H, H8); 1.40-1.21 (m, 
10H, CH
2 
aliph.); 0.82 (t, 3H, J 7.0 Hz, CH
3
); 13C NMR 
(D
2
O, 75 MHz): d 176.3 (C1); 73.7; 72.5; 71.7; 70.9 (C2, 




















: C, 54.84; H, 9.78; N, 7.99; 
Found: C, 55.04 ; H, 9.64 ; N, 8.01. 
N-[2-(N-decyl)-2-aminoethyl]-D-gluconamide 11b: 
0.92 g, 60%; mp 139.3-142 °C (decomposition); IR (KBr) 
ν
max
/cm-1: 3532, 3390, 3351, 2953, 2792, 1661, 1534 and 
1098; 1H NMR (300 MHz, D
2
O): d  4.41 (d, 1H, J 3.0 
Hz, H2); 4.20 (m, 1H, H3); 3.86-3.79 (m, 2H, H4, H6); 
3.75-3.71 (m, 1H, H5); 3.70-3.62 (m, 2H, CONHCH
2
); 




NH); 3.11 (t, 2H, J 7.3 
Hz, H7); 1.78-1.66 (m, 2H, H8); 1.47-1.26 (m, 14H, CH
2 
aliph.); 0.90 (t, 3H, J 6.6 Hz, CH
3
); 13C NMR (75 MHz, 
D
2
O): d 176.3 (C1); 74.6; 73.8; 72.5; 71.1 (C2, C3, C4, C5); 













1,08 g, 60%; mp 177.2-183.8 °C; IR (KBr) ν
max
/cm-1: 
3532, 3391, 3353, 2953, 2792, 1661, 1534 and 1098; 1H 




D): d  7.83 (ls, 1H, CONH); 
5.37-5.30 (m, 2H, H2,
 
H3); 5.08-4.95 (m, 1H, H4); 4.76 
(m, 3H, H6, H5); 4.43 (m, 2H, CONHCH
2





NH); 3.81 (m, 2H, H7); 2.37 (m, 2H, H8); 1.88 
(ls, 18H, CH
2 
aliph.); 1.43 (t, 3H, J 6.6 Hz, CH
3





D): d 179.0 (C1); 76.4; 75.1; 74.5; 72.9 













11d: 0.96 g, 55%; mp 177.2-183.8 °C; IR (KBr) ν
max
/
cm-1: 3505, 3385, 3276, 2954, 2815, 1655, 1538 and 1099; 




D): d 7.75 (ls, 1H, CONH); 




H5, H6); 3.95-3.81 (m, 3H, H4, 
CONHCH
2




NH); 1.81 (m, 
2H, H8); 1.47(m, 24H, CH
2 
aliph.); 1.03 (m, 3H, CH
3
); 




D): d 178.9 (C-1); 76.2; 74.7; 














0.74 g, 50%; mp 186.7-188 °C; IR (KBr) ν
max
/cm-1: 
3541, 3406, 3294, 2954, 2787, 1658, 1534 and 1095; 1H 
NMR (300MHz, D
2
O): d 4.32 (d, 1H, J 3.2 Hz, H2); 4.07 
(ls, 1H, H3); 3.82-3.77 (m, 1H, H4); 3.74 (ls, 2H, H6); 
3.67-3.59 (m, 1H, H5); 3.46-3.26 (m, 2H, CONHCH
2
); 













NH); 1.71-1.58 (m, 2H, H8); 1.40-1.22 (m, 
10H, CH
2 
aliph.); 0.84 (t, 3H, J 7.1 Hz, CH
3
); 13C NMR 
(75MHz, D
2
O): d 175.5 (C1); 73.9; 72.7; 71.6; 70.9 (C2, 




















0.82 g, 52%; mp 167.0-176.6 °C; IR (KBr) ν
max
/cm-1: 
3530, 3391, 3358, 2954, 2741, 1656, 1536 and 1098; 
1H NMR (300 MHz, D
2
O): d 4.35 (d, 1H, J 4.0 Hz, H2); 
4.10 (ls, 1H, H3); 3.86-3.80 (m, 1H, H4); 3.79-3.74 
(m, 2H, H6); 3.71-3.64 (m, 1H, H5); 3.48-3.31 (m, 2H, 
CONHCH
2











NH); 1.74-1.62 (m, 2H, H8); 1.42-1.23 
(m, 14H, CH
2 
aliph.); 0.86 (t, 3H, J 6.8 Hz, CH
3
); 13C NMR 
(75MHz, D
2
O): d 176.9 (C1); 75.3; 74.1; 72.9; 72.3 (C2, 




















12c: 0.82 g, 49%; mp 156.8-177.9 °C; IR (KBr) ν
max
/cm-1: 
3529, 3391, 3359, 2953, 2782, 1656, 1536 and 1098; 1H 




D): d 7.15 (ls, CONH); 4.90 (ls, 
1H, H2); 4.79 (ls, 1H, H3); 4.43 (ls, 1H, H4); 4.24 (ls, 
3H, H5, H6); 3.66 (ls, 2H, CONHCH
2











NH); 1.83 (ls, 
2H, H8); 1.54-1.22 (m, 18H, CH
2 
aliph.); 0.90 (t, 3H, J 7 
Hz, CH
3




D): d 178.6 (C1); 



















Ribonic acid [(n-heptyl)methylene] hydrazide 14: To 
a solution of hidrazide 13 (0.4 g, 2.2 mmmol) in methanol 
(10 mL) was added a solution of octanal (0.35 mL, 
2.2 mmol). The reaction was stirred at room temperature for 
24 h and concentrated under reduced pressure. The resulting 
hydrazide was recrystallized from acetone, and diethyl ether. 
0.6 g; 93%; mp140.9-143 ºC; [α]
D
 +14,75 (c 1.0; DMSO); 
IR (KBr), ν
max
/cm-1: 3414-3273, 2917-2850, 1656, 1087, 




N): d 11.40 (m, 1H, CONH); 
7.75 (m, 1H, N=CH); 5.26 (m, 1H, H2); 4.91 (m, 1H, H3); 
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4.80-4.44 (m, 2H, H4, H5’); 4.42 (m, 1H, H5); 2.24 (m, 2H, 
N=CH-CH
2




); 1.14 (m, 8H, 
CH
2 
aliph.); 0.82 (t, 3H, J 7.1Hz, CH
3





N): d 170.4 (C1); 152.4 (N=CH); 76.1-73,8 (C2, C3, 















: C, 53.78; 
H, 9.03; N, 9.65. Found: C, 53.57; H, 9.01; N, 9.68.
Ribonic acid [(n-nonyl)methylene] hydrazide 15: 
The same experimental procedure described to prepare 
compound 14 was followed. 0.28 g; 79%; mp: 142-144 ºC; 
[α]
D
 +1.15 (c 1.0; DMSO); IR (KBr), ν
max
/cm-1: 3368-3196, 





d 11.40 (m, 1H, CONH); 7.82 (m, 1H, N=CH); 7.75 (m, 
1H, OH); 7.08 (s, 1H, OH); 6.64 (s, 1H, OH); 6.34 (s, 1H, 
OH); 5.25 (m, 1H, H2); 5.08 (m, 1H, H3); 4.90-4.80 (m, 
2H, H4, H5’); 4.49 (m, 1H, H5); 2.26 (m, 2H, N=CH-CH
2
); 




); 1.16 (m, 12H, CH
2 
aliph.); 
0.86 (t, 3H, J 7.1Hz, CH
3





d 170.5 (C1); 152.6 (N=CH); 76.3-74.0 (C2, C3, C4); 65.4 
(C5); 33.3 (N=CH-C); 32.5-23.4 (CH
2
 aliph.); 14.7 (CH
3
); 








: C, 56.58; H, 9.50; 
N, 8.80. Found: C, 56.31; H, 9.29; N, 8.53.
Biological activity
Tested substances were initially diluted in 100 µL of 
sterilized dimethyl sulfoxide (DMSO)/Tween (1:2, v/v) 
and completed up to 10 mL with sterilized saline. A serial 
dilution was prepared to yield the following concentrations: 
250, 125, 62.5, 31.25 and 15.62 µg mL-1. A screening was 
held to confirm the activity of microorganisms and to select 
strains for the determination of the Minimum Inhibitory 
Concentration (MIC) of new compounds. The strains 
selected were from American Type Culture Collection 
(ATCC): S. aureus ATCC 29213, E.coli ATCC 25723 and 
C. albicans ATCC 10231. 
A microbiologic suspension from cultures previously 
incubated for 24 h (bacteria) and 48 h (fungi) was prepared 
in sterilized saline until a 25% transmittance reading was 
reached at λ  = 580 nm (UV-Vis mini1240, Shimadzu®, 
Japan). The standardized microbiological solution was 
prepared by serial dilution in sterilized saline, and the 
colonies counted in Tryptic Soy Agar (Acumedia®, Canada), 
by plating technique. The dilution which presented 103-104 
CFU mL-1 was selected for further inoculation in Tryptone 
Soy Broth (Merck, Germany) (adapted from The United 
States Pharmacopoeia, 1985).
Four mL of the seeded broth were added to 1 mL 
of the previously diluted solutions. Positive control 
consisted of 4 mL of the seeded broth, 10 µL of sterilized 
DMSO/Tween (1:2, v/v) and 990 µL of sterilized saline. To 
ensure the material remained sterile for the whole assay, a 
negative control was prepared with 4 mL of non-inoculated 
broth, 10 µL of sterilized DMSO/Tween (1:2, v/v) and 
990 µL of sterilized saline. The MIC was evaluated by the 
turbidity of the broth after 24 h (bacteria) and 48 h (fungi) 
incubation. Tests were performed in triplicate.
The antitubercular activity against M. tuberculosis virulent 
strain H37Rv was determined in vitro. Stock solutions of 
tested compounds were prepared in DMSO. The mycobacteria 
was subcultured on Lowenstein-Jensen medium at 37 ºC for 
3 weeks, followed by subculture in Middlebrook 7H9 broth 
medium at 37 ºC for at least 10 days, until bacterial density 
corresponding to a 1.0 McFarland turbidity standard was 
reached. The tests were performed through the microplate 
Alamar Blue assay.39-41 The mycobacteria suspension 
were diluted 1:25 in Middlebrook 7H9 broth medium (4 
× 105 mycobacteria/mL) and 100 µL of serial dilutions of 
compounds in the same medium. After incubation at 37 ºC for 
6 days, 25 µL of a 1:1 (v/v) mixture of Alamar Blue reagent 
and 10% Tween 80 was added and the plates were re-incubated 
at 37 ºC for 24 h. A change in the colour from blue to pink 
was observed in the wells where the mycobacteria grew. The 
visual MICs were defined as the lowest drug concentration 
that prevented the colour change.
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